期刊名称：NPJ BREAST CANCER
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
npj Breast Cancer publishes original research articles, reviews, brief communications, matters arising, meeting reports and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation and studies of the tumor microenvironment.
Instructions to Authors
This section will help you when preparing your manuscript for initial submission and resubmission to npj Breast Cancer. Please ensure that you familiarise yourself with our editorial policies as outlined in our Guide for Authors before submitting your work. An overview of key information on submitting primary research is also available in our brief guide to manuscript submission in PDF format.
For information on our aims and scope, as well as our content types, please refer to the About the journal section.
All manuscripts must be submitted electronically through our online submission system, from which you can upload the cover letter and manuscript files (text, figures and supplementary information, including video) and check on the status of your manuscripts during the review process.
Revised manuscripts should be uploaded through the link provided in the editor's decision letter. Please do not submit revisions as new manuscripts.
The authors must include copies of all related manuscripts with any overlap in authorship that are under consideration or in press elsewhere.
Guide for Authors
View our guide for authors for detailed information on editorial criteria, and how manuscripts are handled by our editors between submission and acceptance for publication.
Manuscripts submitted to npj Breast Cancer do not need to adhere to our formatting requirements at the point of initial submission; formatting requirements only apply at the time of acceptance.
 Download Guide for Authors
Editorial Board
Editor-in-Chief
 Larry Norton, MD
Deputy Physician-in-Chief, Breast Cancer Programs
Memorial Sloan Kettering Cancer Center
NY, USA
Dr. Larry Norton is a board-certified medical oncologist with broad interests in cancer prevention, diagnosis and treatment. His research concerns the basic biology of cancer, the mathematics of tumor causation and growth and the development of approaches to better diagnosis, prevention and drug treatment of the disease. He is involved in many areas of research including identifying the genes that predispose people to cancer or that cause cancer, developing new drugs, monoclonal antibodies that target growth factor receptors and vaccines. A major milestone in his research career was the development of an approach to therapy called "dose density," or "sequential dose density."
Deputy Editor
 Jorge S. Reis-Filho, MD, PhD
Director of Experimental Pathology
Memorial Sloan Kettering Cancer Center
NY, USA
Jorge Reis-Filho is an affiliate member of the Human Oncology and Pathogenesis Program and the Computational Biology Center. Dr. Reis-Filho's research program focuses on the development of an integrated morphological and molecular classification for breast cancers by focusing on special histological types and the identification of novel therapeutic targets for specific subgroups of breast cancer patients, through an integrative analysis of data derived from pathology, massively parallel sequencing and functional genomics.
Associate Editors
 Kathy S. Albain, MD, FACP
Professor of Medicine, Director Breast Clinical Research Program
Loyola University Chicago
IL, USA
Kathy Albain devotes her clinical practice to patients with breast and lung cancer at Loyola's Cardinal Bernardin Cancer Center. Dr. Albain is involved in national research and advisory activities pertaining to breast and lung cancers as well as cancer survivorship and special populations research. She has conducted novel research that addressed gender differences in cancer, survivorship issues and outcome and treatment of special populations.
 Debra L. Barton, PhD
Professor of Nursing
University of Michigan
MI, USA
Debra Barton's area of interest and current research focus on improving the quality of life of female cancer survivors, specifically tied to cancer related fatigue, sexual health, menopausal symptoms, complementary therapy and clinical trials. Dr. Barton's program of research has grown out of involvement and subsequently leadership in the Cancer Clinical Trials Network (CCTN) over the past 11 years.
 Lisa A. Carey, MD
Distinguished Professorship for Breast Cancer Research
University of North Carolina Chapel Hill
NC, USA
Lisa Carey's current research seeks to understand the impact of biology of breast cancer subtypes on response to treatment, and analyses of primary and metastatic tumors to understand why some breast cancers spread to other parts of the body and others don't. She is the Medical Director of the UNC Breast Center and Chief of Hematology/Oncology, and Physician-in-Chief of the N.C. Cancer Hospital.
 Angelo Di Leo, MD, PhD
Head of Sandro Pitigliani Medical Oncology Unit
Hospital of Prato, Istituto Toscano Tumori
Prato, Italy
Angelo Di Leo and colleagues are currently studying breast cancers that express estrogen receptors (ER) and HER2, referred to as ER-positive and HER2-positive, respectively. His team will work to identify which patients could safely avoid chemotherapy, and instead receive a CDK4/6 inhibitor with their targeted therapy.
 Caterina Marchio, PhD
Assoc. Professor
University Turin at Candiolo Cancer Institute - FPO IRCCS
Candiolo, Italy
Caterina Marchiò is an Associate Professor of Pathology and a diagnostic and experimental pathologist at Candiolo Cancer Institute, where she leads the Research Program of the Pathology Unit. Her research interests span from histopathogenesis of breast carcinomas to molecular pathology of special histologic types of breast cancer and genetics of HER2-positive and HER2-low carcinomas. She is actively involved in the standardization of preanalytical conditions in Pathology to ensure optimal tissue preservation and quality of DNA, RNA and antigens to guarantee the success of precision medicine.
 Joseph A. Sparano, MD
Professor of Medicine & Obstetrics, Gynecology and Women's Health
Albert Einstein College of Medicine
NY, USA
Joseph Sparano's research has focused on developmental therapeutic approaches for breast cancer, lymphoma and HIV-associated cancers, and therapeutic application of molecular profiling in cancer. Dr. Sparano serves as Vice Chair of the ECOG-ACRIN Research Group and Vice Chair of the AIDS Malignancy Consortium.
 Zoltan Szallasi, MD
Assistant Professor of Pediatrics
Harvard Medical School
MA, USA
Zoltan Szallasi's postdoctoral research was in the field of molecular pharmacology of cancer at the National Cancer Institute. Dr. Szallasi's group is working on "dual" approaches to answer whether one can identify which patient will respond to a given chemotherapeutic agent or whether there exist different subtypes of genomic instability in breast cancer with prognostic and therapeutic relevance.
Founding Editor
 Clifford A. Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan Kettering Cancer Center
NY, USA
Cliff Hudis is a medical oncologist with research interests in all areas of care related to breast cancer. A particular research focus of his team is the interplay between inflammation, obesity and breast cancer, and they are now actively translating their findings into clinically relevant trials with the potential to reduce the global burden of breast and other cancers.
Editorial Board Members
Sunil Badve, MD Indiana University School of Medicine, Indiana, USA
Gabor Balázsi, PhD Stony Brook University, New York, USA
John M.S. Bartlett, PhD Ontario Institute for Cancer Research Toronto, Ontario, Canada
Powel H. Brown, MD University of Texas, MD Anderson Cancer Center Houston, Texas, USA
Maggie Cheang, MD The Institute of Cancer Research Surrey, London, UK
Lewis A. Chodosh, MD University of Pennsylvania, Pennsylvania, USA
Carsten Denkert, MD, PhD Charité Universitätsmedizin Berlin, Berlin, Germany
Matthew J. Ellis, BSc, MB, BChir, PhD, FRCP Baylor College of Medicine, Texas, USA
Prudence A. Francis, MD Peter MacCallum Cancer Centre, Melbourne, Australia
Benita S. Katzenellenbogen, MD University of Illinois Urbana-Champaign, Illinois, USA
Seema A. Khan, MD Northwestern University Evanston, Illinois, USA
Adrian V. Lee, PhD University of Pittsburgh, Pennsylvania, USA
Ephrat Levy-Lahad, MD Shaare Zedek Medical Center, Jerusalem, Israel
Caterina Marchio, PhD University of Turin, Turin, Italy
Stefan Michiels, PhD Université Paris-Sud Paris, Paris, France
Kenneth Offit, MD, MPH Memorial Sloan Kettering Cancer Center, New York, USA
Edith A. Perez, MD Mayo Clinic Jacksonville, Florida, USA
Stuart J. Schnitt, MD Brigham and Women's Hospital, Massachusetts, USA
Valerie Speirs, PhD Leeds Institute of Cancer & Pathology, Leeds, United Kingdom
Anne Vincent-Salomon, PhD Institut Curie Paris, Paris, France
Geoffrey M. Wahl, MD Salk Institute La Jolla, California, USA
Jedd Wolchok, MD, PhD Memorial Sloan Kettering Cancer Center, New York, USA
Nature Research
Managing Editor: Wanda Layman, PhD
Editorial Director, Life Sciences, Community Journals, NPJs: Arianne Heinrichs, PhD
Peer Review Assistants: Priyanka De, Ayesha Pathan
Editorial Assistants: Rosie Tobutt and Caterina Timu
Senior Editorial Assistant: Molly Jiang
Editorial Assistant Supervisor: Yasmin Esmaeili
Editorial Administration Manager: Colm Pollard
Publisher/Director, Strategic Partnerships Americas & Global NPJs: Andrea Macaluso
Assistant Production Editor: Annabelle Topliss
Production Editors: David Pentney and Annika Jesse
Senior Production Editor: Jessica Hart
Managing Production Editor: Kate Neil
Managing Production Editor: Kate Neil
Operations and Partnerships Manager: Esther Trinh
Senior Marketing Manager: Heather Dunphy
Head of Researcher Experience: Katherine Arundell
VP Editorial, Nature Research and Community Journals: Meredith LeMasurier, PhD
VP Commercial, Nature Research Group: Andrew Douglas
Chief Editorial Advisor, Nature Research: Magdalena Skipper, PhD
|
